Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay
Luisa Galati(European Institute of Oncology), Tarik Gheit(Centre international de recherche sur le cancer), Mathis Ratel(Centre international de recherche sur le cancer), Nathalie Forey(Centre international de recherche sur le cancer), Massimo Tommasino(Centre international de recherche sur le cancer), Gary M. Clifford(Centre international de recherche sur le cancer), Tim Waterboer(German Cancer Research Center), Sandrine McKay‐Chopin(Centre international de recherche sur le cancer), James McKay(Centre international de recherche sur le cancer), Florence Le Calvez‐Kelm(Centre international de recherche sur le cancer), Lea Schroeder(German Cancer Research Center), Jean‐Damien Combes(Centre international de recherche sur le cancer)
Cited by 28
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
|British Journal of Cancer|2003|1.6k